• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Deals

Multiple screens displaying stock tickers and financial information
MedTech

GE HealthCare posts higher revenues amid turbulent tariffs

GE Healthcare posted higher revenues for the fourth quarter and year-end as backlog orders stack up and the impact of tariffs fades.
Joseph Keenan Feb 5, 2026 10:45am
heart over ekg

Medtronic steps up with CathWorks buyout

Feb 4, 2026 9:15am
Miels

GSK's new CEO looking for $2B-$4B deals 'hiding in plain sight'

Feb 4, 2026 7:25am
Doustdar

Novo 'wishes Pfizer luck' with Metsera drug, seeks monthly GLP-1

Feb 4, 2026 5:09am
A ballpoint pen rests on top of a stack of documents ready for signing

China biotech inks $135M deal for remaining rights to vTv med

Feb 2, 2026 10:10am
RNA Concept 3D Render

Roche continues RNA return with $1.7B deal for Sanegene drug

Feb 2, 2026 8:35am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings